Brian Gill Barnett MD

Breast Cancer, Hematologic Oncology

Medical Director/Genentech

17050 Medical Center DrBaton Rouge, LA 70816
Phone+1 225-755-3070
Fax+1 225-755-3085

Dr. Barnett is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Barnett's full profile Already have an account?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Gastroenterology, 2016 - 2022
Tulane UniversityFellowship, Hematology and Medical Oncology, 2004 - 2006
Tulane UniversityResidency, Internal Medicine, 2002 - 2004
University of Mississippi Medical CenterInternship, Internal Medicine, 1998 - 1999
University of Mississippi School of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

LA State Medical License 2002 - 2027

Publications & Presentations

PubMed

20 citations
Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast ...
Christopher Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guerin
Breast Cancer Research and Treatment. 2016-04-23
31 citations
Human leukocyte antigen G expression in breast cancer: role in immunosuppression.
Robert L. Elliott, Xian P. Jiang, Jeffrey T. Phillips, Brian G. Barnett, Jonathan F. Head
Cancer Biotherapy & Radiopharmaceuticals. 2011-05-03
51 citations
Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines.
Jens Rüter, Brian G. Barnett, Ilona Kryczek, Michael J. Brumlik, Benjamin J. Daniel
Frontiers in Bioscience. 2009-01-01

Press Mentions

Merck Dives Into Detailed Phase 3 Data Showing PCSK9 Pill Easily Outswims RivalsMarch 30th, 2026
Cleveland Clinic Enters into Collaboration to Acquire Psilocybin, DMT and MDMA for Clinical InvestigationApril 20th, 2020
OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files an 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersMarch 19th, 2019